Sheffield Bio-Science and Wockhardt Ltd. have formed a global sales, marketing and development alliance under which Sheffield will be the exclusive global sales and distribution partner for recombinant insulin manufactured by Wockhardt. Wockhardt was one of the first companies to have developed, manufactured and marketed Wosulin, recombinant insulin injectables. The company’s biotech park in Aurangabad, India has six dedicated manufacturing facilities. Dr. Habil Khorakiwala, chairman of Wockh...